FDA Panel Declines to Recommend Next Generation IV Opioid

The FDA’s Anesthetic and Analgesic Drug Products Advisory Committee voted 8–7 against recommending approval of IV oliceridine for the management of moderate to severe acute pain in adult patients who require an IV opioid in hospital and similar controlled clinical settings.